Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2024-07-19 00:00:00 ET · period of report 2024-07-17 · accession 0001140361-24-033630 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-19 | 2024-07-17 | ANGO | Burgess Lorinda | Dir | A - Grant | $0.00 | +20.5K | 37.6K | +121% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-17 | A | A | 20,541 | $0.00 | 37,582 | D | — | — | (F1) The acquisition of 20,541 shares of common stock of AngioDynamics, Inc.("AngioDynamics") represents 20,541 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant. |